AstraZeneca PLC Ordinary Shares (AZN)

Cost of Revenue

$11.12B

TTM · Period ending: · USD

AZN logo

AZN Cost of Revenue

Latest reported$11.12B
AZN TTM Cost of Revenue ($0.00 → $11.12B)
High-resolution chart · PNG

AZN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
11,120,000,000
11,070,000,000
10,633,000,000
10,240,000,000
10,520,000,000
10,230,000,000
10,207,000,000
9,790,000,000
8,804,000,000
8,581,000,000
8,268,000,000
8,860,000,000
9,747,000,000
10,785,000,000
12,391,000,000
14,116,000,000
14,891,000,000
14,084,000,000
12,437,000,000
9,337,000,000
6,950,000,000
5,743,000,000
5,299,000,000
5,152,000,000
5,133,000,000
5,212,000,000
4,921,000,000
5,180,000,000
4,982,000,000
4,931,000,000
4,936,000,000
4,524,000,000
4,620,000,000
4,558,000,000
4,318,000,000
4,253,000,000
3,904,000,000
4,016,000,000
4,126,000,000
4,235,000,000
4,376,000,000
4,381,000,000
4,646,000,000
5,044,000,000
5,418,000,000
5,658,000,000
5,842,000,000
5,615,000,000
5,438,000,000
5,448,000,000
5,261,000,000
5,219,000,000
5,255,000,000
5,284,000,000
5,393,000,000
5,607,000,000
5,926,000,000
6,062,000,000
6,026,000,000
6,173,000,000
6,104,000,000
6,074,000,000
6,389,000,000
6,295,000,000
6,034,000,000
6,046,000,000
5,775,000,000
6,222,000,000
6,544,000,000
6,511,000,000
6,598,000,000
6,627,000,000
6,447,000,000
6,485,000,000
6,419,000,000
5,856,000,000
5,790,000,000
5,712,000,000
5,613,000,000
5,423,000,000
5,329,000,000
5,251,000,000
5,356,000,000
5,423,000,000
5,464,000,000
5,402,000,000
5,150,000,000
4,752,000,000
4,634,766,463
4,490,129,561
4,468,999,999
4,459,647,004
4,451,127,069
4,404,763,971
4,361,893,533
3,314,246,528
3,218,000,000
3,270,000,000
3,246,519,704
3,246,519,704
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.